$CRBU
Caribou Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.596
▼-47.47%-$0.539
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCaribou Biosciences, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CRBU down today? It is at $0.596 (-47.47%), and our scanner flagged it 126 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRBU spikes, and full due diligence on CRBU — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRBU 126 times in the last 30 days. Create a free account to track $CRBU, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CRBU is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on CRBU today, peaking at 83.8x its normal volume. Fresh from the SEC: Caribou Biosciences to Evaluate Strategic Alternatives. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystCaribou Biosciences to Evaluate Strategic AlternativesReported securities of $113.8 million as of June 30, 2026 —Reported As of June 30, 2026, Caribou had $113.8 million in cash, cash, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kelly Timothy P Officer | Sold (automatic/other) | -6K | sold 7.8% | 73K | $12K at $1.93 | Feb 25, 26 |
Albertson Tina M. Officer | Sold (automatic/other) | -1K | sold 1.5% | 69K | $2K at $1.96 | Feb 24, 26 |
Khan Ruhi Ahmad Officer | Sold (automatic/other) | -7K | sold 6.2% | 105K | $14K at $1.96 | Feb 24, 26 |
Mcclung Barbara G Officer | Sold (automatic/other) | -7K | sold 1.4% | 482K | $14K at $1.96 | Feb 24, 26 |
Kelly Timothy P Officer | Sold (automatic/other) | -3K | sold 3.8% | 79K | $6K at $1.96 | Feb 24, 26 |
Haurwitz Rachel E. Officer | Acquired (grant/award) | +152K 0.1% of company | added 51% | 447K | n/a | Feb 20, 26 |
Ryali Sriram Officer | Acquired (grant/award) | +55K 0.05% of company | added 100% | 72K | n/a | Feb 20, 26 |
Albertson Tina M. Officer | Acquired (grant/award) | +55K 0.05% of company | added 100% | 70K | n/a | Feb 20, 26 |
Khan Ruhi Ahmad Officer | Acquired (grant/award) | +45K 0.04% of company | added 67% | 112K | n/a | Feb 20, 26 |
Mcclung Barbara G Officer | Acquired (grant/award) | +45K 0.04% of company | added 10% | 489K | n/a | Feb 20, 26 |
Kelly Timothy P Officer | Acquired (grant/award) | +45K 0.04% of company | added 100% | 83K | n/a | Feb 20, 26 |
Haurwitz Rachel E. Officer | Bought (open market) | +20K 0.02% of company | added 0.6% | 3.37M | $20K at $1.02 | Mar 14, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
CRBU is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 22 unusual-volume and momentum alerts on CRBU today, peaking at 83.8x its normal volume. Fresh from the SEC: Caribou Biosciences to Evaluate Strategic Alternatives. A material company disclosure like this is often the real catalyst behind a move of this size.
CRBU last traded at $0.596, down 47.47% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Caribou Biosciences, Inc. Common Stock (CRBU) is next expected to report earnings on Wednesday, November 11, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CRBU Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRBU 126 times in the last 30 days.
CRBU (Caribou Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $122M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRBU for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRBU discussion
Sign in to ask a question or join the discussion.